Skip to Main Content
×
Quiver Logo Get a Free Trial on Quiver Premium Today!
Back to News

Insider Purchase: Director at $RNAC Buys 14,740 Shares

Automated

TIMOTHY A SPRINGER, a director at $RNAC, bought 14,740 shares of the company on 03-18-2025 for an estimated $212,599. This trade was reported by Quiver Quantitative using data from a recent SEC filing. This increased their holdings of this class of stock by approximately 0.2%. Following this trade, they now own 8,546,202 shares of this class of $RNAC stock.

$RNAC Insider Trading Activity

$RNAC insiders have traded $RNAC stock on the open market 55 times in the past 6 months. Of those trades, 26 have been purchases and 29 have been sales.

Here’s a breakdown of recent trading of $RNAC stock by insiders over the last 6 months:

  • TIMOTHY A SPRINGER has made 26 purchases buying 800,680 shares for an estimated $14,369,600 and 0 sales.
  • METIN KURTOGLU (Chief Technology Officer) has made 0 purchases and 14 sales selling 139,596 shares for an estimated $2,513,991.
  • MILOS MILJKOVIC (Chief Medical Officer) has made 0 purchases and 4 sales selling 56,880 shares for an estimated $939,074.
  • CHRISTOPHER M JEWELL (Chief Scientific Officer) has made 0 purchases and 5 sales selling 54,665 shares for an estimated $917,824.
  • CARSTEN BRUNN (President and CEO) has made 0 purchases and 2 sales selling 17,271 shares for an estimated $289,764.
  • BLAINE DAVIS (Chief Financial Officer) has made 0 purchases and 2 sales selling 7,989 shares for an estimated $134,035.
  • EMILY ENGLISH (Chief Operations Officer) has made 0 purchases and 2 sales selling 1,797 shares for an estimated $30,149.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

$RNAC Hedge Fund Activity

We have seen 40 institutional investors add shares of $RNAC stock to their portfolio, and 31 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

  • FMR LLC removed 428,617 shares (-15.0%) from their portfolio in Q4 2024, for an estimated $7,676,530
  • ARTAL GROUP S.A. removed 304,554 shares (-100.0%) from their portfolio in Q3 2024, for an estimated $4,909,410
  • BLACKROCK, INC. added 235,936 shares (+55.7%) to their portfolio in Q4 2024, for an estimated $4,225,613
  • GREAT POINT PARTNERS LLC removed 200,000 shares (-100.0%) from their portfolio in Q4 2024, for an estimated $3,582,000
  • VANGUARD GROUP INC added 186,391 shares (+76.7%) to their portfolio in Q4 2024, for an estimated $3,338,262
  • YALE UNIVERSITY removed 100,000 shares (-100.0%) from their portfolio in Q4 2024, for an estimated $1,791,000
  • ARMISTICE CAPITAL, LLC removed 98,565 shares (-100.0%) from their portfolio in Q4 2024, for an estimated $1,765,299

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

$RNAC Analyst Ratings

Wall Street analysts have issued reports on $RNAC in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

  • BTIG issued a "Buy" rating on 12/19/2024

To track analyst ratings and price targets for $RNAC, check out Quiver Quantitative's $RNAC forecast page.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

Add Quiver Quantitative to your preferred sources on Google Google News Logo

Suggested Articles